These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 31996359)
1. Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1. Rodriguez-Gil JL; Watkins-Chow DE; Baxter LL; Elliot G; Harper UL; Wincovitch SM; Wedel JC; Incao AA; Huebecker M; Boehm FJ; Garver WS; Porter FD; Broman KW; Platt FM; Pavan WJ Dis Model Mech; 2020 Mar; 13(3):. PubMed ID: 31996359 [TBL] [Abstract][Full Text] [Related]
2. In Niemann-Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin. Marshall CA; Watkins-Chow DE; Palladino G; Deutsch G; Chandran K; Pavan WJ; Erickson RP Gene; 2018 Feb; 643():117-123. PubMed ID: 29223359 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of primidone in Niemann-Pick disease type C (NPC)-model cells and mice: Reduction of unesterified cholesterol levels in cells and extension of lifespan in mice. Ashikawa H; Mogi H; Honda T; Nakamura H; Murayama T Eur J Pharmacol; 2021 Apr; 896():173907. PubMed ID: 33503462 [TBL] [Abstract][Full Text] [Related]
7. Npc1 deficiency in the C57BL/6J genetic background enhances Niemann-Pick disease type C spleen pathology. Parra J; Klein AD; Castro J; Morales MG; Mosqueira M; Valencia I; Cortés V; Rigotti A; Zanlungo S Biochem Biophys Res Commun; 2011 Sep; 413(3):400-6. PubMed ID: 21910975 [TBL] [Abstract][Full Text] [Related]
8. Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for Tseng WC; Loeb HE; Pei W; Tsai-Morris CH; Xu L; Cluzeau CV; Wassif CA; Feldman B; Burgess SM; Pavan WJ; Porter FD Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135069 [TBL] [Abstract][Full Text] [Related]
9. Reduction of glutamate neurotoxicity: A novel therapeutic approach for Niemann-Pick disease, type C1. Cougnoux A; Yerger JC; Fellmeth M; Serra-Vinardell J; Navid F; Wassif CA; Cawley NX; Porter FD Mol Genet Metab; 2021 Dec; 134(4):330-336. PubMed ID: 34802899 [TBL] [Abstract][Full Text] [Related]
10. Increased activity and altered subcellular distribution of lysosomal enzymes determine neuronal vulnerability in Niemann-Pick type C1-deficient mice. Amritraj A; Peake K; Kodam A; Salio C; Merighi A; Vance JE; Kar S Am J Pathol; 2009 Dec; 175(6):2540-56. PubMed ID: 19893049 [TBL] [Abstract][Full Text] [Related]
12. Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains. Kodam A; Maulik M; Peake K; Amritraj A; Vetrivel KS; Thinakaran G; Vance JE; Kar S Glia; 2010 Aug; 58(11):1267-81. PubMed ID: 20607864 [TBL] [Abstract][Full Text] [Related]
13. Pneumococcal Immunization Reduces Neurological and Hepatic Symptoms in a Mouse Model for Niemann-Pick Type C1 Disease. Houben T; Magro Dos Reis I; Oligschlaeger Y; Steinbusch H; Gijbels MJJ; Hendrikx T; Binder CJ; Cassiman D; Westerterp M; Prickaerts J; Shiri-Sverdlov R Front Immunol; 2018; 9():3089. PubMed ID: 30666257 [TBL] [Abstract][Full Text] [Related]
14. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele. Praggastis M; Tortelli B; Zhang J; Fujiwara H; Sidhu R; Chacko A; Chen Z; Chung C; Lieberman AP; Sikora J; Davidson C; Walkley SU; Pipalia NH; Maxfield FR; Schaffer JE; Ory DS J Neurosci; 2015 May; 35(21):8091-106. PubMed ID: 26019327 [TBL] [Abstract][Full Text] [Related]
15. Lipidomic Analysis Reveals Altered Fatty Acid Metabolism in the Liver of the Symptomatic Niemann-Pick, Type C1 Mouse Model. Pergande MR; Serna-Perez F; Mohsin SB; Hanek J; Cologna SM Proteomics; 2019 Sep; 19(18):e1800285. PubMed ID: 31394590 [TBL] [Abstract][Full Text] [Related]
16. Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. Patel SC; Suresh S; Kumar U; Hu CY; Cooney A; Blanchette-Mackie EJ; Neufeld EB; Patel RC; Brady RO; Patel YC; Pentchev PG; Ong WY Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1657-62. PubMed ID: 9990080 [TBL] [Abstract][Full Text] [Related]
17. Quantitative, Label-Free Proteomics in the Symptomatic Niemann-Pick, Type C1 Mouse Model Using Standard Flow Liquid Chromatography and Thermal Focusing Electrospray Ionization. Pergande MR; Nguyen TTA; Haney-Ball C; Davidson CD; Cologna SM Proteomics; 2019 May; 19(9):e1800432. PubMed ID: 30888112 [TBL] [Abstract][Full Text] [Related]
18. Hearing loss is an early consequence of Npc1 gene deletion in the mouse model of Niemann-Pick disease, type C. King KA; Gordon-Salant S; Pawlowski KS; Taylor AM; Griffith AJ; Houser A; Kurima K; Wassif CA; Wright CG; Porter FD; Repa JJ; Brewer CC J Assoc Res Otolaryngol; 2014 Aug; 15(4):529-41. PubMed ID: 24839095 [TBL] [Abstract][Full Text] [Related]
19. The C57BL/6J Niemann-Pick C1 mouse model with decreased gene dosage has impaired glucose tolerance independent of body weight. Jelinek D; Castillo JJ; Garver WS Gene; 2013 Sep; 527(1):65-70. PubMed ID: 23769925 [TBL] [Abstract][Full Text] [Related]
20. Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrin. Cougnoux A; Clifford S; Salman A; Ng SL; Bertin J; Porter FD Mol Genet Metab; 2018 Dec; 125(4):345-350. PubMed ID: 30392741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]